Skip to content

In-Home Technology for Caregivers of People With Dementia and Mild Cognitive Impairment

Developing and Evaluating In-Home Supportive Technology for Caregivers of People With Dementia and Mild Cognitive Impairment

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04206670
Enrollment
216
Registered
2019-12-20
Start date
2020-03-10
Completion date
2021-12-08
Last updated
2022-05-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alzheimer Disease, Dementia, Mild Cognitive Impairment

Keywords

Caregivers, Dementia, Mild Cognitive Impairment, In-Home Technology, Alzheimer Disease

Brief summary

This study aims to develop and evaluate new in-home supportive technology that is designed to alleviate anxiety, burden, and loneliness in spousal and familial caregivers of individuals with Alzheimer's disease, other dementias, or mild cognitive impairment.

Detailed description

This study aims to develop, refine, and evaluate a new hardware/software system designed to integrate in-home sensors and devices, Internet-of-Things technologies (i.e., devices that can be controlled and communicated with via the internet), and social networking to create a more safe and supportive home environment for caregivers and people who have Alzheimer's disease, other dementias, or mild cognitive impairment. The system monitors troublesome behaviors in people with dementia or mild cognitive impairment (e.g., wandering), and targets mechanisms (e.g., worry, social isolation) thought to link behavioral symptoms in people with dementia or mild cognitive impairment with adverse caregiver outcomes (declines in health and well-being). The system is designed to minimize demands on caregivers' limited time and energy and to provide a platform for data collection that can be used by researchers and care professionals. Hypotheses: 1. Caregivers in the full operation condition will have fewer negative effects of caregiving (lower burden, better mental and physical health, higher well-being) than those in the control condition. 2. Greater use of the social networking features of the system will be associated with fewer caregiver depressive symptoms. 3. Greater utilization of the home safety features of the system will be associated with fewer caregiver anxiety symptoms.

Interventions

DEVICEIn-Home Technology System and Questionnaires

Participants self-install the in-home technology system in their homes after enrollment in the study (i.e., consent procedures and initial questionnaire). Intelligent bots monitor the in-home sensors, learn typical patterns, and provide caregivers with text messages via cell phone and alerts via the tablet when worrisome behaviors occur. Social contact is encouraged using caregiver resources and a trusted circle of friends and family who are encouraged to stay in contact with the caregiver and person with dementia or mild cognitive impairment.

DEVICEWaiting Control In-Home Technology System and Questionnaires

Participants self-install the in-home technology system in their homes six months after their enrollment in the study (i.e., consent procedures and initial questionnaire). Intelligent bots monitor the in-home sensors, learn typical patterns, and provide caregivers with text messages via cell phone and alerts via the tablet when worrisome behaviors occur. Social contact is encouraged using caregiver resources and a trusted circle of friends and family who are encouraged to stay in contact with the caregiver and person with dementia or mild cognitive impairment.

Sponsors

People Power Company
CollaboratorINDUSTRY
National Institute on Aging (NIA)
CollaboratorNIH
University of California, San Francisco
CollaboratorOTHER
University of California, Berkeley
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Investigator)

Masking description

Participants are randomly assigned to treatment arms by People Power. All participants complete the same questionnaires at the same intervals. University of California, Berkeley investigators are blind as to participants' treatment arm assignment.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Caregivers are fluent/literate in English * Caregivers currently reside with spouse/family member who has received a diagnosis of Alzheimer's disease, other dementias, or mild cognitive impairment * Caregivers primarily use a smartphone (e.g., iPhone, Android) * Caregiver has wireless internet in home

Exclusion criteria

* Caregivers providing care for individuals with known non-neurodegenerative conditions affecting behavior and cognition * Caregivers providing care for individuals with longstanding Axis I psychiatric disorder * Caregivers providing care for individuals with metabolic disorder or major organ dysfunction * Caregivers providing care for individuals with alcohol abuse or dependence (within 5 years of dementia onset) * Caregivers providing care for individuals with head trauma with loss of consciousness greater than 30 minutes * Caregivers providing care for individuals with contraindications to MRI imaging * Caregivers providing care for individuals with large confluent white matter lesions * Caregivers providing care for individuals with significant systemic medical illness * Caregivers providing care for individuals who use a medication likely to affect central nervous system functions adversely

Design outcomes

Primary

MeasureTime frameDescription
3 Months Assessment for Center for Epidemiological Studies Depression Scale (CES-D)3 months after baselineQuestionnaire to measure depression (Radloff, 1977). 20 items are rated on a 0-3 scale and summed (range = 0-60). There are no subscales. Higher scores represent worse outcomes. The clinical cut-off is usually set at a score of 16.
6 Months Assessment for Center for Epidemiological Studies Depression Scale (CES-D)6 months after baselineQuestionnaire to measure depression (Radloff, 1977). 20 items are rated on a 0-3 scale and summed (range = 0-60). There are no subscales. Higher scores represent worse outcomes. The clinical cut-off is usually set at a score of 16.
3 Months Assessment for Zarit Burden Interview-Short Form3 months after baselineQuestionnaire to measure caregiver burden (Zarit, Reever, & Bach-Peterson, 1980). 12 items are rated on 0-4 scale. Range: 0-48. No subscales. Higher scores represent worse outcomes.
6 Months Assessment for Zarit Burden Interview-Short Form6 months after baselineQuestionnaire to measure caregiver burden (Zarit, Reever, & Bach-Peterson, 1980). 12 items are rated on 0-4 scale. Range: 0-48. No subscales. Higher scores represent worse outcomes.
3 Months Assessment for Beck Anxiety Inventory (BAI)3 months after baselineQuestionnaire to measure anxiety (Beck, Epstein, Brown, & Steer, 1988). 20 items are rated on a 0-3 scale and summed (range= 0-60). Higher scores indicate worse outcomes. There are no subscales. A score greater than 36 is considered to be clinically significant.
6 Months Assessment for Beck Anxiety Inventory (BAI)6 months after baselineQuestionnaire to measure anxiety (Beck, Epstein, Brown, & Steer, 1988). 20 items are rated on a 0-3 scale and summed (range= 0-60). Higher scores indicate worse outcomes. There are no subscales. A score greater than 36 is considered to be clinically significant.
3 Months Assessment for Satisfaction With Life Scale3 months after baselineQuestionnaire measuring overall life satisfaction and well-being (Diener, Emmons, Larsen, & Griffin, 1985). 5 items scored on a 1-7 scale and summed (Range = 5-35). Lower scores indicate worse outcomes. A score of 20 is considered neutral with higher scores considered increasingly more satisfied and lower scores considered increasingly more dissatisfied.
6 Months Assessment for Satisfaction With Life Scale6 months after baselineQuestionnaire measuring overall life satisfaction and well-being (Diener, Emmons, Larsen, & Griffin, 1985). 5 items scored on a 1-7 scale and summed (Range = 5-35). Lower scores indicate worse outcomes. A score of 20 is considered neutral with higher scores considered increasingly more satisfied and lower scores considered increasingly more dissatisfied.

Countries

United States

Participant flow

Pre-assignment details

Note that outcomes are only assessed regarding caregiver health and well-being. Patients did not provide any information; therefore, all information reported for demographics and measures is only regarding caregivers.

Participants by arm

ArmCount
In-Home Technology System
Participants (N=300) will receive and install the full system (sensors for entry, activity, temperature, water leak; voice control; digital display; local router) in their homes. Remote assistance will be provided to help with the installation. Sensors, warnings, messaging, and social networking features will be activated remotely. Participation will extend over a six month period with questionnaires (e.g., health and well-being) administered 3 times (at the time of installation and every 3 months thereafter). In-Home Technology System and Questionnaires: Participants self-install the in-home technology system in their homes after enrollment in the study (i.e., consent procedures and initial questionnaire). Intelligent bots monitor the in-home sensors, learn typical patterns, and provide caregivers with text messages via cell phone and alerts via the tablet when worrisome behaviors occur. Social contact is encouraged using caregiver resources and a trusted circle of friends and family who are encouraged to stay in contact with the caregiver and person with dementia or mild cognitive impairment.
148
Waiting Control
Participants (N=300) will receive and install the full system (sensors for entry, activity, temperature, water leak; voice control; digital display; local router) in their homes. Remote assistance will be provided to help with the installation. Sensors, warnings, messaging, and social networking features will be activated remotely. Participation will extend over a six month period with questionnaires (e.g., health and well-being) administered 3 times (at the time of installation and every 3 months thereafter). In-Home Technology System and Questionnaires: Participants self-install the in-home technology system in their homes after enrollment in the study (i.e., consent procedures and initial questionnaire). Intelligent bots monitor the in-home sensors, learn typical patterns, and provide caregivers with text messages via cell phone and alerts via the tablet when worrisome behaviors occur. Social contact is encouraged using caregiver resources and a trusted circle of friends and family who are encouraged to stay in contact with the caregiver and person with dementia or mild cognitive impairment.
68
Total216

Baseline characteristics

CharacteristicTotalIn-Home Technology SystemWaiting Control
Age, Continuous63.9 years
STANDARD_DEVIATION 11.2
63.7 years
STANDARD_DEVIATION 11.8
64.6 years
STANDARD_DEVIATION 9.8
Beck Anxiety Inventory8.02 units on a scale
STANDARD_DEVIATION 7.94
7.36 units on a scale
STANDARD_DEVIATION 8.23
9.46 units on a scale
STANDARD_DEVIATION 7.12
Center for Epidemiologic Studies Depression Scale16.01 units on a scale
STANDARD_DEVIATION 10.22
15.14 units on a scale
STANDARD_DEVIATION 10.04
17.90 units on a scale
STANDARD_DEVIATION 10.44
Race/Ethnicity, Customized
Black or African American
11 Participants8 Participants3 Participants
Race/Ethnicity, Customized
East Asian, South Asian, Southeast Asian, or Indian American
13 Participants9 Participants4 Participants
Race/Ethnicity, Customized
Latino or Hispanic American
12 Participants8 Participants4 Participants
Race/Ethnicity, Customized
Native Hawaiian or Pacific Islander
2 Participants1 Participants1 Participants
Race/Ethnicity, Customized
Non-Hispanic White or European American
159 Participants108 Participants51 Participants
Race/Ethnicity, Customized
Other
19 Participants14 Participants5 Participants
Satisfaction with Life20.30 units on a scale
STANDARD_DEVIATION 7.18
20.99 units on a scale
STANDARD_DEVIATION 7.24
18.81 units on a scale
STANDARD_DEVIATION 6.85
Sex: Female, Male
Female
141 Participants90 Participants51 Participants
Sex: Female, Male
Male
75 Participants58 Participants17 Participants
Zarit Burden Inventory20.45 units on a scale
STANDARD_DEVIATION 8.53
20.04 units on a scale
STANDARD_DEVIATION 8.71
21.35 units on a scale
STANDARD_DEVIATION 8.13

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 1480 / 68
other
Total, other adverse events
0 / 1480 / 68
serious
Total, serious adverse events
0 / 1480 / 68

Outcome results

Primary

3 Months Assessment for Beck Anxiety Inventory (BAI)

Questionnaire to measure anxiety (Beck, Epstein, Brown, & Steer, 1988). 20 items are rated on a 0-3 scale and summed (range= 0-60). Higher scores indicate worse outcomes. There are no subscales. A score greater than 36 is considered to be clinically significant.

Time frame: 3 months after baseline

ArmMeasureValue (MEAN)Dispersion
In-Home Technology System3 Months Assessment for Beck Anxiety Inventory (BAI)8.06 units on a scaleStandard Deviation 7.71
Waiting Control3 Months Assessment for Beck Anxiety Inventory (BAI)9.29 units on a scaleStandard Deviation 7.55
Primary

3 Months Assessment for Center for Epidemiological Studies Depression Scale (CES-D)

Questionnaire to measure depression (Radloff, 1977). 20 items are rated on a 0-3 scale and summed (range = 0-60). There are no subscales. Higher scores represent worse outcomes. The clinical cut-off is usually set at a score of 16.

Time frame: 3 months after baseline

ArmMeasureValue (MEAN)Dispersion
In-Home Technology System3 Months Assessment for Center for Epidemiological Studies Depression Scale (CES-D)16.05 units on a scaleStandard Deviation 10.3
Waiting Control3 Months Assessment for Center for Epidemiological Studies Depression Scale (CES-D)18.39 units on a scaleStandard Deviation 10.27
Primary

3 Months Assessment for Satisfaction With Life Scale

Questionnaire measuring overall life satisfaction and well-being (Diener, Emmons, Larsen, & Griffin, 1985). 5 items scored on a 1-7 scale and summed (Range = 5-35). Lower scores indicate worse outcomes. A score of 20 is considered neutral with higher scores considered increasingly more satisfied and lower scores considered increasingly more dissatisfied.

Time frame: 3 months after baseline

ArmMeasureValue (MEAN)Dispersion
In-Home Technology System3 Months Assessment for Satisfaction With Life Scale21.26 units on a scaleStandard Deviation 6.96
Waiting Control3 Months Assessment for Satisfaction With Life Scale18.68 units on a scaleStandard Deviation 7.11
Primary

3 Months Assessment for Zarit Burden Interview-Short Form

Questionnaire to measure caregiver burden (Zarit, Reever, & Bach-Peterson, 1980). 12 items are rated on 0-4 scale. Range: 0-48. No subscales. Higher scores represent worse outcomes.

Time frame: 3 months after baseline

ArmMeasureValue (MEAN)Dispersion
In-Home Technology System3 Months Assessment for Zarit Burden Interview-Short Form20.40 units on a scaleStandard Deviation 9.19
Waiting Control3 Months Assessment for Zarit Burden Interview-Short Form21.31 units on a scaleStandard Deviation 8.63
Primary

6 Months Assessment for Beck Anxiety Inventory (BAI)

Questionnaire to measure anxiety (Beck, Epstein, Brown, & Steer, 1988). 20 items are rated on a 0-3 scale and summed (range= 0-60). Higher scores indicate worse outcomes. There are no subscales. A score greater than 36 is considered to be clinically significant.

Time frame: 6 months after baseline

ArmMeasureValue (MEAN)Dispersion
In-Home Technology System6 Months Assessment for Beck Anxiety Inventory (BAI)7.81 units on a scaleStandard Deviation 8.44
Waiting Control6 Months Assessment for Beck Anxiety Inventory (BAI)8.71 units on a scaleStandard Deviation 6.53
Primary

6 Months Assessment for Center for Epidemiological Studies Depression Scale (CES-D)

Questionnaire to measure depression (Radloff, 1977). 20 items are rated on a 0-3 scale and summed (range = 0-60). There are no subscales. Higher scores represent worse outcomes. The clinical cut-off is usually set at a score of 16.

Time frame: 6 months after baseline

ArmMeasureValue (MEAN)Dispersion
In-Home Technology System6 Months Assessment for Center for Epidemiological Studies Depression Scale (CES-D)15.98 units on a scaleStandard Deviation 11.61
Waiting Control6 Months Assessment for Center for Epidemiological Studies Depression Scale (CES-D)17.17 units on a scaleStandard Deviation 9.55
Primary

6 Months Assessment for Satisfaction With Life Scale

Questionnaire measuring overall life satisfaction and well-being (Diener, Emmons, Larsen, & Griffin, 1985). 5 items scored on a 1-7 scale and summed (Range = 5-35). Lower scores indicate worse outcomes. A score of 20 is considered neutral with higher scores considered increasingly more satisfied and lower scores considered increasingly more dissatisfied.

Time frame: 6 months after baseline

ArmMeasureValue (MEAN)Dispersion
In-Home Technology System6 Months Assessment for Satisfaction With Life Scale21.28 units on a scaleStandard Deviation 7.51
Waiting Control6 Months Assessment for Satisfaction With Life Scale18.66 units on a scaleStandard Deviation 7.06
Primary

6 Months Assessment for Zarit Burden Interview-Short Form

Questionnaire to measure caregiver burden (Zarit, Reever, & Bach-Peterson, 1980). 12 items are rated on 0-4 scale. Range: 0-48. No subscales. Higher scores represent worse outcomes.

Time frame: 6 months after baseline

ArmMeasureValue (MEAN)Dispersion
In-Home Technology System6 Months Assessment for Zarit Burden Interview-Short Form20.93 units on a scaleStandard Deviation 9.17
Waiting Control6 Months Assessment for Zarit Burden Interview-Short Form21.87 units on a scaleStandard Deviation 8.86

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026